https://www.selleckchem.com/pr....oducts/salubrinal.ht
without prior HIV drug resistance, sustains viral suppression and yields better lipid profiles. This finding supports its use as switching therapy in patients receiving PI-based regimens due to intolerance to efavirenz and NVP and previous alternatives limited to PI in resource-limited settings. © 2020 The Authors. Journal of the International AIDS Society published by John Wiley Sons Ltd on behalf of the International AIDS Society.OBJECTIVE Our objective was to characterize Canadian workforce attributes of extended role practi
Like
Comment
Share
